Research on immunotherapy conducted at the Department of Oncology is presented in a feature article in the popular national Norwegian newspaper Verdens Gang (VG) January 9th. The article focuses on recent progress in chimeric antigen receptor (CAR) T cell therapy. For two years, children with leukemia and adults with lymphoma has been treated through clinical studies. Now the project will be expanded with three new studies on lymphomas.
Published in major journals, first or last author from Oslo University Hospital.
In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten Challenge
Adv Sci (Weinh), 8 (4), 2003526
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Sci Transl Med, 13 (582)
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
Sci Adv, 7 (8)